| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Merck & Co., Inc. (MRK) has 26 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. MRK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 456.9K | $51.84M | - | |
| VP | 197.9K | $22.45M | - | |
| Dir | 108.3K | $12.29M | - | |
| Pres | 96.8K | $10.98M | - | |
| CFO | 94.2K | $10.69M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2022 | Frazier Kenneth C | Executive Chair | Sale+OE | 235,769 | $99.55 | $23,471,432.58 | -9.0% | +4.6% | +6.8% | |
| Nov 7, 2022 | Oosthuizen Johannes Jacobus | President, U.s. Market | Sale+OE | 45,561 | $99.47 | $4,531,980.01 | -71.1% | +4.6% | +6.8% | |
| Nov 4, 2022 | Frazier Kenneth C | Executive Chair | Sale+OE | 470,000 | $98.66 | $46,372,118.02 | -14.1% | +5.0% | +7.1% | |
| Nov 2, 2022 | Frazier Kenneth C | Executive Chair | Sale+OE | 600,000 | $99.86 | $59,914,706.34 | -13.9% | +8.8% | +6.3% | |
| Oct 31, 2022 | Frazier Kenneth C | Executive Chair | Sale+OE | 867,084 | $100.44 | $87,090,363.48 | -16.4% | +5.5% | +4.3% | |
| Oct 28, 2022 | Oosthuizen Johannes Jacobus | President, U.s. Market | Sale+OE | 3,633 | $100.21 | $364,064.75 | -25.0% | +6.8% | +4.8% | |
| Oct 28, 2022 | Mizell Steven50 | EVP, Chief Hr Officer | Sale+OE | 25,000 | $99.63 | $2,490,720.00 | -25.7% | +6.8% | +4.8% | |
| Oct 28, 2022 | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sale+OE | 164,557 | $100.26 | $16,499,093.68 | -54.6% | +6.8% | +4.8% | |
| Oct 28, 2022 | Zachary Jennifer | EVP, General Counsel | Sale+OE | 165,255 | $99.38 | $16,422,892.71 | -53.9% | +6.8% | +4.8% | |
| Oct 28, 2022 | Chattopadhyay Sanat | Exe V-p &Pres. Mmd | Sale+OE | 100,292 | $100.10 | $10,039,379.64 | -68.7% | +6.8% | +4.8% |